Estradiol; Norethindrone Acetate Patent Expiration
Estradiol; Norethindrone Acetate was first introduced by Noven Pharmaceuticals Inc
Estradiol; Norethindrone Acetate Patents
Given below is the list of patents protecting Estradiol; Norethindrone Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Combipatch | US5656286 | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
Aug 12, 2014
(Expired) | Noven Pharms Inc |
| Combipatch | US6024976 | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
Jan 07, 2014
(Expired) | Noven Pharms Inc |
| Combipatch | US5474783 | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
Dec 12, 2012
(Expired) | Noven Pharms Inc |
| Combipatch | US5958446 | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
Dec 12, 2012
(Expired) | Noven Pharms Inc |
Estradiol; Norethindrone Acetate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List